METALLOTHIONEIN AND LIVER CANCER IN THE LEC RAT
METALLOTHIONEIN AND LIVER CANCER IN THE LEC RAT
批准号:
2101995
负责人:
MICHAEL L SCHILSKY
金额:
$21.42万
依托单位国家:
美国
项目类别:
财政年份:
1993
资助国家:
美国
项目状态:
已结题
起止时间:
1993-12-15 至 1997-11-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goal of this study is to determine the role of metallothionein (MT)
in the development and prevention of hepatocellular carcinoma (HCC). The
model to be used for these proposed studies is the Long-Evans Cinnamon
(LEC) rat, a mutant breed of rats wit inherited copper toxicosis which
spontaneously develop HCC. MT, by virtue of this multifunctional role in
copper metabolism where it serves as a metal transporter, donor and
detoxifier, is key to understanding the pathogenesis and prevention of
HCC in these animals. The proposed studies focus on copper-MT metabolism
in the LEC rat. Specific aspects of Cu-MT metabolism to be evaluated
include the timetable for its induction, the subcellular distribution of
MT and copper, and the possible defect in lysosomal metabolism of Cu-MT.
Analysis of the efficacy of in-vivo treatment of copper toxicosis for
preventing the progression to HCC in LEC rats and its effect on the
cellular metabolism of copper-Mt will help further define MT's role in
cellular trans-formation. Other studies will focus on the underlying
cellular defect in copper and MT metabolism which leads to the
accumulation of hepatic copper-MT in LEC hepatocytes. These studies are
made possible by newly developed temperature dependent immortalized cell
lines derived from LEC and control rats. Further study of the role of
lysosomes in hepatocellular MT metabolism will be achieved by development
of in-vitro assays for the lysosomal import of MT.
Study of this unique model of aberrant copper metabolism will help
elucidate the role of copper and MT in the process of hepatic
carcinogenesis, and provide information from which future therapies for
the prevention and treatment of HCC may be formulated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
INITIAL THERAPY OF WILSON'S DISEASE
-
批准号:6295036
-
项目类别:
-
资助金额:$0.17万
-
财政年份:1998
-
负责人:MICHAEL L SCHILSKY
-
依托单位:
INITIAL THERAPY OF WILSONS DISEASE
-
批准号:6295018
-
项目类别:
-
资助金额:$0.17万
-
财政年份:1998
-
负责人:MICHAEL L SCHILSKY
-
依托单位:
INITIAL THERAPY OF WILSON'S DISEASE
-
批准号:6158308
-
项目类别:
-
资助金额:$0.17万
-
财政年份:1998
-
负责人:MICHAEL L SCHILSKY
-
依托单位:
INITIAL THERAPY OF WILSONS DISEASE
-
批准号:6265961
-
项目类别:
-
资助金额:$0.17万
-
财政年份:1998
-
负责人:MICHAEL L SCHILSKY
-
依托单位:
HEPATIC DISORDERS OF HEAVY METAL METABOLISM
-
批准号:6254338
-
项目类别:
-
资助金额:$1.77万
-
财政年份:1997
-
负责人:MICHAEL L SCHILSKY
-
依托单位:
METALLOTHIONEIN AND LIVER CANCER IN THE LEC RAT
-
批准号:2101994
-
项目类别:
-
资助金额:$14.94万
-
财政年份:1993
-
负责人:MICHAEL L SCHILSKY
-
依托单位:
METALLOTHIONEIN AND LIVER CANCER IN THE LEC RAT
-
批准号:2008332
-
项目类别:
-
资助金额:$23.74万
-
财政年份:1993
-
负责人:MICHAEL L SCHILSKY
-
依托单位:
METALLOTHIONEIN AND LIVER CANCER IN THE LEC RAT
-
批准号:2101996
-
项目类别:
-
资助金额:$22.57万
-
财政年份:1993
-
负责人:MICHAEL L SCHILSKY
-
依托单位:
HEPATIC BIOSYNTHESIS OF CERULOPLASMIN
-
批准号:3080814
-
项目类别:
-
资助金额:$7.69万
-
财政年份:1989
-
负责人:MICHAEL L SCHILSKY
-
依托单位:
HEPATIC BIOSYNTHESIS OF CERULOPLASMIN
-
批准号:3080815
-
项目类别:
-
资助金额:$9.02万
-
财政年份:1989
-
负责人:MICHAEL L SCHILSKY
-
依托单位:
HEPATIC BIOSYNTHESIS OF CERULOPLASMIN
-
批准号:3080816
-
项目类别:
-
资助金额:$8.97万
-
财政年份:1989
-
负责人:MICHAEL L SCHILSKY
-
依托单位:
HEPATIC BIOSYNTHESIS OF CERULOPLASMIN
-
批准号:3080813
-
项目类别:
-
资助金额:$7.69万
-
财政年份:1989
-
负责人:MICHAEL L SCHILSKY
-
依托单位:
HEPATIC BIOSYNTHESIS OF CERULOPLASMIN
-
批准号:3080817
-
项目类别:
-
资助金额:$9.07万
-
财政年份:1989
-
负责人:MICHAEL L SCHILSKY
-
依托单位:
COPPER INHIBITION OF PROTEIN SYNTHESIS IN HEPATOCYTES
-
批准号:3036803
-
项目类别:
-
资助金额:$2.9万
-
财政年份:1988
-
负责人:MICHAEL L SCHILSKY
-
依托单位:
COPPER INHIBITION OF PROTEIN SYNTHESIS IN HEPATOCYTES
-
批准号:3036804
-
项目类别:
-
资助金额:$2.63万
-
财政年份:1988
-
负责人:MICHAEL L SCHILSKY
-
依托单位:
海外基金